Alpa Laboratories Share Price | Alpa Laboratories Stock Screener
ALPA
Pharmaceuticals
Share Price NSE
₹68.41
▼
-0.31 (-0.45%)
Share Price BSE
₹68.05
▼
-0.40 (-0.58%)
As of July 6, 2026, the Alpa Laboratories share price (NSE: ALPA) is ₹68.41 on NSE and ₹68.05 on BSE, down 0.45% from the previous close, with shares trading between ₹67.50 and ₹70.50, and a 52-week range of ₹46.46–₹104.20.
Analyse Alpa Laboratories stock price data download and track historical price performance.
Use the Alpa Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Alpa Laboratories Market Cap
₹143.12 Cr.
ALPA P/E Ratio (TTM)
9.68
Alpa Laboratories P/B Ratio
0.78
EPS (TTM)
₹0.24
Dividend Yield
-
Debt to Equity
0.02
ALPA 52 Week High
₹104.20
Alpa Laboratories 52 Week Low
₹46.46
Operating Margin
11.00%
Profit Margin
3.23%
ALPA Revenue (TTM)
₹31.00
EBITDA
₹3.00
Net Income
₹1.00
Total Assets
₹242.00
Total Equity
₹186.00
Alpa Laboratories Share Price Chart
Screen Alpa Laboratories share price with an interactive chart. Analyse ALPA price trends and volatility across different timeframes.
Alpa Laboratories Company Profile - Fundamental Screener
Screen Alpa Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ALPA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE385I01010
Alpa Laboratories Balance Sheet Screener
Screen ALPA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 242 | 223 | 182 | 167 | 155 | 140 | 121 | 121 | 122 | 126 |
| Current Assets | 211 | 193 | 161 | 149 | 138 | 121 | 96 | 94 | 98 | 105 |
| Fixed Assets | 20 | 21 | 12 | 7 | 9 | 7 | 6 | 8 | 10 | 15 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 3 | 5 | 2 | 3 | 2 | 0 | 0 | 0 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 186 | 171 | 152 | 135 | 122 | 108 | 100 | 99 | 98 | 95 |
| Share Capital | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves & Surplus | 165 | 150 | 131 | 114 | 101 | 87 | 79 | 78 | 77 | 74 |
Alpa Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Alpa Laboratories income statement and profit fundamentals.
Analyze ALPA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Alpa Laboratories share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 31 | 42 | 31 | 29 | 30 | 28 | 27 | 27 | 32 | 35 | 29 | 30 | 35 | 31 | 27 |
| Expenses | 28 | 40 | 19 | 29 | 28 | 20 | 21 | 21 | 22 | 25 | 20 | 27 | 29 | 25 | 24 |
| EBITDA | 3 | 3 | 12 | 1 | 2 | 8 | 6 | 6 | 10 | 10 | 9 | 3 | 6 | 6 | 3 |
| Operating Profit % | 11.00% | 1.00% | 2.00% | -9.00% | 5.00% | 15.00% | 2.00% | 2.00% | 13.00% | 3.00% | 32.00% | -4.00% | 10.00% | 9.00% | 4.00% |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3 | 2 | 12 | 0 | 2 | 7 | 5 | 5 | 10 | 9 | 8 | 3 | 6 | 5 | 2 |
| Tax | 2 | 4 | 0 | 0 | 0 | 3 | 0 | 0 | 2 | 0 | 3 | 0 | 0 | 1 | 6 |
| Net Profit | 1 | -2 | 12 | 0 | 2 | 4 | 5 | 5 | 8 | 9 | 5 | 3 | 6 | 5 | -4 |
| EPS | 0.24 | -0.95 | 5.59 | 0.05 | 0.76 | 1.71 | 2.42 | 2.42 | 3.66 | 4.23 | 2.12 | 1.44 | 2.75 | 2.17 | -1.70 |
Alpa Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen ALPA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 18 | 4 | 9 | 10 | -2 | 18 | -1 | -13 | 17 | -22 |
| Investing Activities | -12 | -13 | 2 | -16 | 6 | -11 | -15 | -12 | -2 | -8 |
| Financing Activities | -5 | 3 | -4 | 5 | 0 | -1 | -5 | 9 | -15 | -6 |
| Net Cash Flow | 1 | -7 | 7 | 0 | 4 | 5 | -20 | -15 | 0 | -36 |
Alpa Laboratories Shareholding Pattern Screener
See Alpa Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Alpa Laboratories promoter holding and ownership changes for ALPA on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 57.19% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% |
| FII Holding | 0.38% | 0.40% | 0.36% | 0.35% | 0.36% | 0.50% | 0.36% | 0.74% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 36.75% | 37.32% | 37.28% | 37.14% | 36.78% | 36.83% | 36.65% | 36.09% |
| Other Holding | 5.68% | 4.99% | 5.06% | 5.21% | 5.57% | 5.37% | 5.70% | 5.87% |
| Shareholder Count | 17,900 | 18,872 | 18,851 | 18,542 | 18,236 | 18,690 | 18,116 | 18,885 |
Alpa Laboratories Share Dividend Screener - Share Yield Analysis
Check Alpa Laboratories dividend history with payout and yield data.
View Alpa Laboratories dividend details including ex-dates and amounts for ALPA stock.
Alpa Laboratories Stock Index Membership
See which indices include Alpa Laboratories stock.
Check ALPA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Alpa Laboratories Market Events Screener - Corporate Actions
Get Alpa Laboratories corporate actions including splits, bonuses, and buybacks.
Check Alpa Laboratories stock events that may affect ALPA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.36% | ||
| Annual General Meeting | NA | 10.89% | ||
| Annual General Meeting | NA | -9.25% | ||
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 1.19% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | 17.61% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -5.54% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -5.48% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 4.02% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -12.57% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -1.67% |
Alpa Laboratories Competitors Screener - Peer Comparison
Screen ALPA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 449,827 | 38.82 | 58,220 | 6.38% | 11,565 | 65.03 |
| Divis Laboratories | 174,081 | 69.38 | 10,560 | 8.73% | 2,520 | 43.32 |
| Torrent Pharmaceuticals | 157,634 | 71.51 | 13,886 | 20.34% | 2,138 | 66.05 |
| Cipla | 117,459 | 30.13 | 29,045 | 2.24% | 3,870 | 68.02 |
| Dr Reddys Laboratories | 114,822 | 27.10 | 33,593 | -0.44% | 3,998 | 73.77 |
| Zydus Life Science | 112,829 | 21.63 | 26,720 | 13.65% | 5,242 | 66.06 |
| Lupin | 110,115 | 20.00 | 27,488 | 19.98% | 5,345 | 66.98 |
| Mankind Pharma | 102,623 | 52.44 | 14,278 | 12.03% | 1,750 | 59.48 |
| Aurobindo Pharma | 89,879 | 25.78 | 33,385 | 3.21% | 3,376 | 65.10 |
| Laurus Labs | 80,995 | 88.02 | 6,868 | 22.01% | 890 | 70.64 |
Alpa Laboratories Company Announcements - News Screener
Screen ALPA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-03 | Closure of Trading Window | - |
| 2026-05-29 | Results For The Quarter And Year Ended March2026 | - |
| 2026-05-12 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-04-11 | Appointment of Company Secretary and Compliance Officer | - |
| 2026-04-09 | Clarification | - |
| 2026-04-08 | Clarification Sought from Alpa Laboratories Ltd | - |
| 2026-03-20 | Closure of Trading Window | - |
| 2026-03-09 | Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-09 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | - |
| 2026-02-25 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2026-02-11 | Alpa Laboratories Limited Has Submitted To The Exchange The Financial Results For The Period Ended December 31 2025. | - |
| 2026-02-11 | Board Meeting Outcome for Financial Results | - |
| 2026-01-29 | Board Meeting Intimation for Consider And Approve The Financial Results For The Period Ended December 31 2025 | - |
| 2025-11-14 | Financial Results For The Quarter And Half Year Ended September 302025 | - |
| 2025-11-04 | Board Meeting Intimation for Board Meeting Intimation | - |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2025-09-27 | Closure of Trading Window | - |
| 2025-09-05 | Book Closure For The Purpose Of Annual General Meeting. | - |
| 2025-09-04 | Reg. 34 (1) Annual Report. | - |